Page 26 - Linical Evolution News Today

The company reportedly will utilize the investment funding to expand its research platform, and to advance six of its preclinical therapeutic programs.

ERT, Bioclinica merger unites clinical trial tech teams The combination of companies brings together ERT’s clinical endpoint data capabilities and Bioclinica’s imaging, eClinical and drug-safety solutions. ERT and Bioclinica have sealed the deal on their merger, combining Bioclinica’s imaging, eClinical, and drug-safety capabilities; with ERT’s eCOA, cardiac, respiratory, and wearable expertise. According to company leaders, the union gives clients access to ...

A leader from the mobile research nursing specialist offers advice on what to look for in a service provider, and why finding the right one is vital. With COVID-19 causing a surge in decentralized trials, pharmaceutical firms and their research teams increasingly are looking to qualified technology and service providers to help bring the studies to the patients, in their homes. Gerard Barron, vice president of operations for Illingworth Research Group, a Syneos Healt...

The two companies plan to collaboratively explore ways to combine 3D printing and nanotechnology, in order to create nanoparticle-enabled dosage forms.

Canine cancer research startup impacts treatment in humans One Health’s FidoCure is using genomics and AI technology to develop precision oncological treatments, and the work is benefiting human cancer research. Cancer is an insidious disease that doesn’t merely affect people; dogs and other companion animals are prone to developing various forms of cancer, too. According to the American Veterinary Medical Association, cancers attack dogs at roughly the same rate...

UK launches human challenge trial on COVID-19 reinfection A human challenge trial has been launched in the UK to investigate what happens when people who have already had COVID-19 are infected a second time. The aim of the study is to see what kind of immune response is required to stop people being re-infected; as well as investigate how the immune system reacts to re-exposure. As a challenge trial, the study will purposefully infect healthy volunteers with the viru...

(Vitaliia Hryshchenko/iStock via Getty Images Plus) A leader from the trial tech firm says COVID-19 has accelerated virtual studies, creating opportunities to improve patient engagement, costs and data. Thanks to the global pandemic, clinical research stands at a crossroads. The surge in adoption of decentralized and hybrid trial models has sites and sponsors asking how the landscape will look in the coming months and years, and how can industry professionals make be...

The Institute for Clinical and Economic Review will use Aetion observational real-world evidence to evaluate potential drugs from Takeda and CSL Behring. The Institute for Clinical and Economic Review (ICER), a non-profit research institute that evaluates potential therapies and medical devices, announced it will turn to observational real-world evidence (RWE) analyzed by Aetion to update its 2018 assessments of three potential angioedema treatments. The treatments a...